Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics.

MLA

Papachristos, Apostolos, et al. “Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics.” Cancers, vol. 15, no. 12, June 2023, p. 3233. EBSCOhost, https://doi.org/10.3390/cancers15123233.

APA

Papachristos, A., Patel, J., Vasileiou, M., & Patrinos, G. P. (2023). Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics. Cancers, 15(12), 3233. https://doi.org/10.3390/cancers15123233

Chicago

Papachristos, Apostolos, Jai Patel, Maria Vasileiou, and George P. Patrinos. 2023. “Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics.” Cancers 15 (12): 3233. doi:10.3390/cancers15123233.